Literature DB >> 2524837

Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.

G Utermann1, F Hoppichler, H Dieplinger, M Seed, G Thompson, E Boerwinkle.   

Abstract

The lipoprotein (a) [Lp(a)] contains two nonidentical protein species, apolipoprotein (apo) B-100 and a specific high molecular weight glycoprotein, apo(a). Lp(a) represents a continuous quantitative genetic trait, the genetics of which are only poorly understood. Genetic variation at the apo(a) locus affects plasma Lp(a) levels and explains at least 40% of the variability of this trait. Lp(a) levels were found to be elevated 3-fold in the plasma from patients with the heterozygous form of familial hypercholesterolemia who have one mutant low density lipoprotein receptor gene. This elevation was not due to a higher frequency of those apo(a) types that are associated with high Lp(a) levels in familial hypercholesterolemia patients. Rather Lp(a) levels were elevated for each of the apo(a) phenotypes examined. The effects of the apo(a) and low density lipoprotein receptor genes on Lp(a) levels are not additive but multiplicative. This is a situation not commonly considered in quantitative human genetics. We conclude that Lp(a) levels in plasma may be determined by variation at more than one gene locus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2524837      PMCID: PMC287411          DOI: 10.1073/pnas.86.11.4171

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man.

Authors:  G Utermann; M Hees; A Steinmetz
Journal:  Nature       Date:  1977-10-13       Impact factor: 49.962

2.  The genetics of the Lp antigen. II. A family study and proposed models of genetic control.

Authors:  C F Sing; J S Schultz; D C Shreffler
Journal:  Ann Hum Genet       Date:  1974-07       Impact factor: 1.670

3.  Three alleles for quantitative Lp(a).

Authors:  S J Hasstedt; R R Williams
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

4.  Human plasma lipoprotein [a]. Structural properties.

Authors:  J W Gaubatz; C Heideman; A M Gotto; J D Morrisett; G H Dahlen
Journal:  J Biol Chem       Date:  1983-04-10       Impact factor: 5.157

5.  Binding of LP(a) to the low density lipoprotein receptor of human fibroblasts.

Authors:  L Havekes; B J Vermeer; T Brugman; J Emeis
Journal:  FEBS Lett       Date:  1981-09-28       Impact factor: 4.124

6.  Purification and quantitation of the human plasma lipoprotein carrying the Lp(a) antigen.

Authors:  C Ehnholm; H Garoff; K Simons; H Aro
Journal:  Biochim Biophys Acta       Date:  1971-05-25

7.  Assignment of the human gene for the low density lipoprotein receptor to chromosome 19: synteny of a receptor, a ligand, and a genetic disease.

Authors:  U Francke; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

8.  Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.

Authors:  F Krempler; G M Kostner; A Roscher; F Haslauer; K Bolzano; F Sandhofer
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

9.  Protein composition of Lp(a) lipoprotein from human plasma.

Authors:  G Utermann; W Weber
Journal:  FEBS Lett       Date:  1983-04-18       Impact factor: 4.124

10.  Diverging effects of cholestyramine on apolipoprotein B and lipoprotein Lp(a). A dose-response study of the effects of cholestyramine in hypercholesterolaemia.

Authors:  B Vessby; G Kostner; H Lithell; J Thomis
Journal:  Atherosclerosis       Date:  1982-07       Impact factor: 5.162

View more
  42 in total

Review 1.  The Gordon Wilson Lecture. Plasma cholesterol: atherogenesis and mortality.

Authors:  W R Fisher
Journal:  Trans Am Clin Climatol Assoc       Date:  1993

2.  Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

Authors:  C Sandholzer; G Feussner; J Brunzell; G Utermann
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

3.  Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

Authors:  C Lackner; E Boerwinkle; C C Leffert; T Rahmig; H H Hobbs
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

4.  Lipoprotein (a): a possible link between lipoprotein metabolism and thrombosis.

Authors:  A Rees
Journal:  Br Heart J       Date:  1991-01

5.  Expressed hypervariable polymorphism of apolipoprotein (a).

Authors:  M I Kamboh; R E Ferrell; B A Kottke
Journal:  Am J Hum Genet       Date:  1991-11       Impact factor: 11.025

Review 6.  Lipoprotein (a). Heterogeneity and biological relevance.

Authors:  A M Scanu; G M Fless
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

Authors:  C Sandholzer; E Boerwinkle; N Saha; M C Tong; G Utermann
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

8.  Serum LP(A) levels in randomized healthy men from different European countries.

Authors:  M Cigolini; J C Seidell; M G Zenti; G Bonadonna; L Zambelli; J P Deslypere; F Contaldo; A Cruz; J Charzewska; G Targher
Journal:  Eur J Epidemiol       Date:  1993-09       Impact factor: 8.082

9.  Hyperlipoproteinaemia(a) is a common cause of autosomal dominant hypercholesterolaemia.

Authors:  E Meriño-Ibarra; J Puzo; E Jarauta; A Cenarro; D Recalde; A L García-Otín; E Ros; E Martorell; X Pintó; M Franco; D Zambón; A Brea; M Pocoví; F Civeira
Journal:  J Inherit Metab Dis       Date:  2007-10-20       Impact factor: 4.982

10.  The interaction between coagulation factor 2 receptor and interleukin 6 haplotypes increases the risk of myocardial infarction in men.

Authors:  Bruna Gigante; Anna M Bennet; Karin Leander; Max Vikström; Ulf de Faire
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.